The Risks of the Inspire Implant: How I Counsel My Patients

This is how I talk with my own patients about the risks of Inspire when we sit down for an informed-consent discussion. Researching these complications — so I can prevent them — has been a focus of my career, and every number on this page comes from the published literature, including my own studies, all cited at the bottom.

Please note: this is not a substitute for the informed-consent discussion you will have with your own provider, and it doesn’t represent a complete, verbatim consent process — it’s simply a representation of the conversation I have with my patients, nothing more. I hope you find it helpful as you go through this process with your own surgeon.

On this page
  1. The big picture
  2. Bleeding
  3. Infection
  4. Nerve injuries
  5. Pneumothorax
  6. Neck tightness from the wire
  7. Scarring
  8. Hardware problems
  9. Not a guaranteed cure
  10. Every number in one place
  11. My research on complications

First, the big picture

Inspire is, by the standards of surgery for sleep apnea, a remarkably safe procedure. In the pivotal STAR trial, serious procedure-related events occurred in fewer than 2% of patients in the first year,[5] and the large post-approval ADHERE registry reported similarly low rates of serious events.[7] In my own research comparing Inspire directly against traditional sleep surgery across matched patients from a national health-records network, the difference was striking:[11]

From my 2022 study of a ~70-million-patient records network; the comparison against multilevel sleep surgery was similar (3% vs 21% complications).[11] A separate study I co-authored found 30-day return-to-operating-room rates of 0.1% for Inspire vs 4.8% for traditional airway surgery.[12]

Transparency: I consult for Inspire Medical Systems — a relationship disclosed in those studies as well. Full disclosures are on my About page.

“Safer than the alternatives” is not the same as “risk-free,” though. Here is the actual conversation I have with every patient.

Bleeding

Bleeding can happen after any surgery. Here it can present as a hematoma — a lump of clotted blood under the skin. It can happen at either site, but in my experience it almost always happens at the chest, and would be rare in the neck. Sometimes it’s just more bruising than expected; other times it’s a lump, and at times quite a large one. When I’ve seen this, it has always been at the chest site. In my experience, this happens about 1% of the time.

The main thing that makes bleeding more likely is blood-thinning medication — common things like aspirin, Plavix, Eliquis, and Coumadin. These are typically held before surgery, but never stop them on your own: how long each one needs to be held differs by medication, and the decision has to be coordinated with your surgeon and the doctor who prescribed it. It may be reasonable to continue low-dose aspirin through the procedure, since the bleeding risk with low-dose aspirin alone may be minimal — but again, that’s a conversation for you and your physician. The other thing that puts people at risk is not following the activity restrictions after surgery — resuming activity too soon may raise your risk of bleeding.

If excessive bruising or a small, non-growing hematoma forms, most often nothing needs to be done. Your body will absorb the clot over time, and you’ll heal completely normally.

Infection

Thankfully, the risk of infection with Inspire is low — but when it happens, the consequences can be severe. Nationally, the calculated incidence works out to roughly half a percent.[9] I published my own center’s numbers, and I’ll be candid about them: infection occurred in 3 of 215 patients (1.4%) — and all three ultimately required removal of the device.[4] That is exactly why I do everything in my power to prevent it. Your surgeon may or may not choose these same measures, but it could be worth a conversation:

  • A staph/MRSA decolonization protocol before surgery — a special (chlorhexidine) soap over the neck and chest for five days before surgery, along with a mouthwash and a nasal ointment. In a landmark randomized trial of essentially this same regimen, deep surgical-site infections fell by roughly 79%,[1] and the orthopedic implant literature showed the same pattern — including zero staph infections among 321 decolonized joint-replacement carriers in one prospective study.[2],[3] I use it routinely for every patient.
  • Prepping the surgical site and giving IV antibiotics before the incision — standard, and always done.
  • During surgery, I irrigate the surgical wound with saline containing antibiotics.
  • A few days of antibiotic pills at home afterward.

With all of this done, the risk of infection is very low — typically around or under 1%. (For honesty’s sake: all three infections in our published series occurred across the whole study period; since standardizing this protocol, our own rate has been under 1% too.[4]) If an infection does develop and it’s caught early and isn’t too deep, it may be treatable with antibiotics alone. But at times, the device may have to be completely removed.

~0.5%calculated national incidence of infection[9]
1.4%infection rate in my center’s published series (3 of 215)[4]
↓79%deep surgical-site infections in the landmark trial of this decolonization regimen[1]

Injury to the nerves we work around

There are two nerves near the surgical field. The first you know about: the hypoglossal nerve, the nerve that controls your tongue — the one we’re stimulating. The second you may not: the nerve that controls your lower lip.

Either nerve can be weak after surgery, and when it happens, it’s almost always temporary. If the tongue nerve is weak, you may notice your tongue bending slightly to the right when you stick it straight out, a bit of slurred speech or a minor lisp, or — in more significant cases — trouble swallowing. Mild, temporary tongue weakness was fairly common in the early trial era, but as a discrete complication it shows up in under 1% of registry patients — and no case of permanent tongue weakness was reported in either the STAR trial or the ADHERE registry.[5],[7] Permanent weakness is possible, but in my experience it is very, very rare.

The lower-lip nerve is very small and sits close to where we operate, and even a small stretch can weaken it temporarily. After a right-sided implant, you might notice in a big smile that the right side of your lower lip doesn’t pull down quite as much as the left. This almost always improves with time, but a subtle — or occasionally more noticeable — asymmetry can persist, and even a very careful surgery can’t avoid this 100% of the time. It’s important you’re aware of it: in one of my studies, patients in online support groups brought up lip weakness far more often than official databases record it (6.8% of patient-described events vs 0.4% of federal reports)[13] — one of the reasons I make a point of discussing it before surgery.

Pneumothorax (a collapsed lung) — a risk the newest device has essentially eliminated

In earlier generations of the device, a separate breathing-sensor lead was placed in the chest, and with it came a small risk of pneumothorax — air around the lung. I led a national study on exactly this question, and the answer was reassuring but instructive: among experienced, high-volume sleep surgeons the rate was 0.21% (8 in 3,823 implants), versus 3.4% in a general surgical population — a sixteen-fold difference.[10] When it happened, it often required a chest tube — half the cases in my study, and most of those in the national database.[9],[10]

Today, this is largely history: the current generation — Inspire V — no longer uses a separate sensing lead at all, so with Inspire V there is very little to no pneumothorax risk. I include it here because it’s a good example of how this technology has matured, and because the underlying lesson from my study still applies to every risk on this page: your surgeon’s experience with this specific operation matters. It’s a fair question to ask any surgeon: how many of these have you done?

Neck tightness from the connecting wire

Inspire’s stimulation cuff sits in the neck and the battery sits in the chest, connected by a small wire tunneled beneath the skin. Over time that wire can scar to the surrounding tissue, and when it scars, it can get stuck in place. What that sometimes looks like: when you look straight up at the ceiling, you can feel — even see — a tight band in the neck.

This almost always gets better with time, and many patients never notice it at all. The best prevention is neck rolls, using a protocol I originally developed that has since spread around the country: ten full circles one way, ten the other, at least three to five times a day in the weeks after surgery, to keep the wire mobile before scar can fix it in place. Don’t be alarmed by some early tightness — that’s fairly normal and should dissipate. But you should know that in some patients the band can be tight and uncomfortable enough that they’ve requested removal of the device or a surgical revision to fix it.

Scarring

Any incision forms scar tissue, and people heal differently. Some heal so well the scar is essentially invisible; others form hypertrophic scars or keloids — large, noticeable scars that can be painful and bothersome. If you know you form these, tell your provider so measures can be taken to mitigate a painful or unsightly scar. Unpleasant scarring isn’t expected, but it can happen to any patient.

Hardware problems

We’re now on the fifth generation of the Inspire device. It’s a mature technology, and many of the hardware problems of earlier years have been resolved — problems people faced in the past are no longer likely to occur. That said, any medical device can ultimately fail, and Inspire is no different. The hardware can malfunction in different ways, and a malfunction can require revision surgery or replacement of that part.

To put numbers on it: in the largest real-world analysis, about 1.5% of patients needed some revision surgery within the first year, rising to about 3.6% by year three; device removal occurred in 0.7% by year one and 2.7% by year three.[8] My own center’s experience with the breathing-sensor lead of earlier generations: 2.1% of our patients needed a revision for a sensing-lead malfunction[14] — a component Inspire V no longer has at all, which is exactly the kind of maturation I’m describing. Rarely — about 0.2% of cases nationally — a lead can even work its way through the skin; I’ve published on how we successfully manage that without losing the device.[15]

And one thing that isn’t a complication — but you need to know it

Inspire is not a guaranteed cure. It’s not guaranteed to cure your sleep apnea, not guaranteed to cure your snoring, and not guaranteed that you’ll tolerate the stimulation. Rarely, we have patients who don’t improve at all — even when we expected them to do well beforehand, the surgery was technically flawless, and the device works exactly as designed. For reasons we don’t always completely understand, it just doesn’t help their sleep apnea.

The published numbers match that honesty: in the pivotal trial’s five-year follow-up, roughly two-thirds to three-quarters of patients met the formal definition of surgical success,[6] and in my own center’s series it was about 77% — which also means roughly one patient in four falls short of that bar.[16] Many of those still improve meaningfully; a few don’t. You should be aware of this scenario and know that Inspire is not a guarantee.

Please also be aware that the Inspire battery lasts about ten years, so you will need repeat surgeries roughly every ten to eleven years to replace it.

Every number in one place

RiskWhat the data showSource
Serious events<2% in the first year (trial); 6% cumulative over 5 years, mostly elective device adjustments[5] [6]
Stimulation discomfortCommon early (up to 40% report it at some point in year one), usually mild and settles with adjustment; 8–12% at registry visits[5] [7]
Tongue soreness/abrasionUp to 21% (soreness incl. abrasion) in the trial’s first year; abrasion specifically 3–4% in the registry[5] [7]
Temporary tongue weaknessFairly common (mild) early in the trial era; <1% as a discrete registry event; no permanent case reported in trial or registry[5] [7]
Hematoma / bleeding~1% in my experience; rare in published series[9]
Infection~0.5% calculated national incidence; 1.4% in my published series (all requiring removal); explant-for-infection 0.38% per implant in the largest real-world study[4] [8] [9]
PneumothoraxHistorical (sensing-lead era): 0.21% with experienced sleep surgeons vs 3.4% in general practice. Inspire V has no sensing lead — very little to no risk with the current device[9] [10]
Revision surgery~1.5% by year one; ~3.6% by year three[8]
Device removal~0.7% by year one; ~2.7% by year three[8]
Sensing-lead malfunction2.1% requiring revision in my center’s series[14]
Lead extrusion~0.2% nationally; manageable, sometimes without device removal[15]
Surgical successRoughly two-thirds to three-quarters at 5 years (trial); ~77% in my center’s series — not a guarantee[6] [16]

A note on reading these numbers honestly: different studies count differently. Trial percentages count anyone who ever reported a symptom during follow-up of a small cohort; registry and database figures count discrete events across thousands of patients. Where the ranges differ, I’ve shown both.

My research on complications

I find it critical to have a really thorough discussion with each of my patients about the possible risks — and it’s been a focus of my career to research complications as much as possible, so that I can prevent them from happening as much as I can. These are the studies I’ve contributed to the literature specifically on the safety of this procedure:

Published studies I’ve co-authored on HNS safety & complications

  1. Van Daele DJ, Cromwell JW, Hsia JK, Nord RS. Post-operative Complication Rate Comparison Between Airway Surgery and Upper Airway Stimulation Using NSQIP and ADHERE. OTO Open. 2021;5(4). doi:10.1177/2473974X211051313
  2. Nord R, Fitzpatrick T, DeShazo JP, Reiter ER. Comparison of readmission and complication rates between traditional sleep surgery and hypoglossal nerve stimulation. Laryngoscope Investig Otolaryngol. 2022;7(5):1659-1666. doi:10.1002/lio2.883
  3. Nord R, DeShazo JP, Grenda T, Gonsalves C, Elliott Z, Huntley C, Boon M. Pneumothorax during upper airway stimulation: Does experience make a difference? Am J Otolaryngol. 2022;43:103577. doi:10.1016/j.amjoto.2022.103577
  4. Bentan MA, Dawood E, Moffatt D, Suurna MV, Nord R. Are There Hidden Adverse Events in Hypoglossal Nerve Stimulation? Comparing Social Media and a Federal Database. Laryngoscope. 2024;134(12):5217-5222. doi:10.1002/lary.31589
  5. Bentan MA, Nord R. Comprehensive Analysis of Adverse Events Associated With Hypoglossal Nerve Stimulators: Insights From the MAUDE Database. Otolaryngol Head Neck Surg. 2024;171(5):1580-1590. doi:10.1002/ohn.883
  6. Ali NS, Fitzpatrick TH IV, Islam AS, Nord RS. Mitigating Infection Risk in Upper Airway Stimulation. Ann Otol Rhinol Laryngol. 2024;133(3):277-283. doi:10.1177/00034894231209540
  7. Islam AS, Pingree G, Chafin A, Fitzpatrick TH IV, Nord RS. Respiratory Sensing Lead Malfunction in Upper Airway Stimulation: A Single Institution Report. Laryngoscope. 2024;134(3):1479-1484. doi:10.1002/lary.31056
  8. Adibi I, Saeedi A, Calder AN, Nord R. Hypoglossal Nerve Stimulator Lead Extrusion: Successful Management and Reimplantation. OTO Open. 2025;9(3):e70169. doi:10.1002/oto2.70169

References

  1. Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17. doi:10.1056/NEJMoa0808939
  2. Rao N, Cannella BA, Crossett LS, Yates AJ Jr, McGough RL 3rd, Hamilton CW. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection: prospective cohort study with 2-year follow-up. J Arthroplasty. 2011;26(8):1501-1507. doi:10.1016/j.arth.2011.03.014
  3. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010;92(9):1820-1826. doi:10.2106/JBJS.I.01050
  4. Ali NS, Fitzpatrick TH IV, Islam AS, Nord RS. Mitigating Infection Risk in Upper Airway Stimulation. Ann Otol Rhinol Laryngol. 2024;133(3):277-283. doi:10.1177/00034894231209540
  5. Strollo PJ Jr, Soose RJ, Maurer JT, et al; STAR Trial Group. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139-149. doi:10.1056/NEJMoa1308659
  6. Woodson BT, Strohl KP, Soose RJ, et al. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes. Otolaryngol Head Neck Surg. 2018;159(1):194-202. doi:10.1177/0194599818762383
  7. Thaler E, Schwab R, Maurer J, et al. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscope. 2020;130(5):1333-1338. doi:10.1002/lary.28286
  8. Moroco AE, Wei Z, Byrd I, et al. Device-related outcomes following hypoglossal nerve stimulator implantation. J Clin Sleep Med. 2024;20(9):1497-1503. doi:10.5664/jcsm.11176
  9. Bentan MA, Nord R. Comprehensive Analysis of Adverse Events Associated With Hypoglossal Nerve Stimulators: Insights From the MAUDE Database. Otolaryngol Head Neck Surg. 2024;171(5):1580-1590. doi:10.1002/ohn.883
  10. Nord R, DeShazo JP, Grenda T, Gonsalves C, Elliott Z, Huntley C, Boon M. Pneumothorax during upper airway stimulation: Does experience make a difference? Am J Otolaryngol. 2022;43:103577. doi:10.1016/j.amjoto.2022.103577
  11. Nord R, Fitzpatrick T, DeShazo JP, Reiter ER. Comparison of readmission and complication rates between traditional sleep surgery and hypoglossal nerve stimulation. Laryngoscope Investig Otolaryngol. 2022;7(5):1659-1666. doi:10.1002/lio2.883
  12. Van Daele DJ, Cromwell JW, Hsia JK, Nord RS. Post-operative Complication Rate Comparison Between Airway Surgery and Upper Airway Stimulation Using NSQIP and ADHERE. OTO Open. 2021;5(4). doi:10.1177/2473974X211051313
  13. Bentan MA, Dawood E, Moffatt D, Suurna MV, Nord R. Are There Hidden Adverse Events in Hypoglossal Nerve Stimulation? Comparing Social Media and a Federal Database. Laryngoscope. 2024;134(12):5217-5222. doi:10.1002/lary.31589
  14. Islam AS, Pingree G, Chafin A, Fitzpatrick TH IV, Nord RS. Respiratory Sensing Lead Malfunction in Upper Airway Stimulation: A Single Institution Report. Laryngoscope. 2024;134(3):1479-1484. doi:10.1002/lary.31056
  15. Adibi I, Saeedi A, Calder AN, Nord R. Hypoglossal Nerve Stimulator Lead Extrusion: Successful Management and Reimplantation. OTO Open. 2025;9(3):e70169. doi:10.1002/oto2.70169
  16. Nord RS, Fitzpatrick T IV, Pingree G, Islam A, Chafin A. Should lateral wall collapse be a contraindication for hypoglossal nerve stimulation? Am J Otolaryngol. 2024;45:104053. doi:10.1016/j.amjoto.2023.104053